Great Basin Multiplex Staph ID/R Blood Culture Panel Gets FDA Clearance | GenomeWeb

NEW YORK (GenomeWeb) – Great Basin Scientific today announced it has received 510(k) clearance from the US Food and Drug Administration for its multiplex Staph ID/R Blood Culture Panel.

The test is an automated assay for simultaneous identification of Staphylococcus aureus and other Staphylococcus species, as well as the mecA drug-resistance gene. The test also supports antimicrobial stewardship by identifying coagulase-negative staphylococci, part of the normal flora of human skin that can lead to false positive blood culture. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.